These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33147453)

  • 21. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
    Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
    Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.
    Kagita A; Lung MSY; Xu H; Kita Y; Sasakawa N; Iguchi T; Ono M; Wang XH; Gee P; Hotta A
    Stem Cell Reports; 2021 Apr; 16(4):985-996. PubMed ID: 33711268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems.
    Wu H; Liu Q; Shi H; Xie J; Zhang Q; Ouyang Z; Li N; Yang Y; Liu Z; Zhao Y; Lai C; Ruan D; Peng J; Ge W; Chen F; Fan N; Jin Q; Liang Y; Lan T; Yang X; Wang X; Lei Z; Doevendans PA; Sluijter JPG; Wang K; Li X; Lai L
    Cell Mol Life Sci; 2018 Oct; 75(19):3593-3607. PubMed ID: 29637228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants for Efficient Editing with Cas9-Mediated Recombineering in
    Choudhury A; Fankhauser RG; Freed EF; Oh EJ; Morgenthaler AB; Bassalo MC; Copley SD; Kaar JL; Gill RT
    ACS Synth Biol; 2020 May; 9(5):1083-1099. PubMed ID: 32298586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).
    Perera OP; Little NS; Pierce CA
    PLoS One; 2018; 13(5):e0197567. PubMed ID: 29771955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface.
    Lu ZH; Li J; Dmitriev IP; Kashentseva EA; Curiel DT
    ACS Nano; 2022 Jul; 16(7):10443-10455. PubMed ID: 35749339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing.
    Liu X; Xiong W; Qi Q; Zhang Y; Ji H; Cui S; An J; Sun X; Yin H; Tian T; Zhou X
    Nucleic Acids Res; 2022 May; 50(8):4769-4783. PubMed ID: 35446403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage.
    Zuo Z; Liu J
    Curr Opin Struct Biol; 2020 Jun; 62():166-174. PubMed ID: 32070859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-Mediated Genome Editing of Trichoderma reesei.
    Zou G; Zhou Z
    Methods Mol Biol; 2021; 2234():87-98. PubMed ID: 33165782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.
    Zhang Q; Xing HL; Wang ZP; Zhang HY; Yang F; Wang XC; Chen QJ
    Plant Mol Biol; 2018 Mar; 96(4-5):445-456. PubMed ID: 29476306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision Genome Editing with CRISPR-Cas9.
    Rahman S; Ikram AR; Azeem F; Tahir Ul Qamar M; Shaheen T; Mehboob-Ur-Rahman
    Methods Mol Biol; 2024; 2788():355-372. PubMed ID: 38656525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome Editing in Mice Using CRISPR/Cas9 Technology.
    Hall B; Cho A; Limaye A; Cho K; Khillan J; Kulkarni AB
    Curr Protoc Cell Biol; 2018 Dec; 81(1):e57. PubMed ID: 30178917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
    Ui-Tei K; Maruyama S; Nakano Y
    Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
    Sandoval IM; Collier TJ; Manfredsson FP
    Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.